These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Comparative toxicity of carminomycin, rubomycin and adriamycin in mice and experience with carminomycin in spontaneous tumors of dogs. Syrkin AB; Kiselev AV Oncology; 1980; 37 Suppl 1():67-70. PubMed ID: 6935578 [TBL] [Abstract][Full Text] [Related]
26. Phase I-II evaluation of carminomycin in adults with acute leukemia. Debusscher L; Malarme M; Bron D; Rozencweig M; Stryckmans P Eur J Cancer Clin Oncol; 1985 Jan; 21(1):31-4. PubMed ID: 3855751 [TBL] [Abstract][Full Text] [Related]
27. [Comparative study of the effects of carminomycin 13-cyclohexylidenehydrazone and carminomycin on several immunologic responses of the body]. Malkova IV; Shapovalova SP Antibiotiki; 1984 May; 29(5):374-7. PubMed ID: 6378085 [TBL] [Abstract][Full Text] [Related]
28. [Antileukemic activity of carminomycin complexes with a high-polymer DNA]. Vaĭnberg IuP; Egorov LV; Kuznetsova TV; Rudneva NA; Khanykova OK Antibiotiki; 1980 Jun; 25(6):454-8. PubMed ID: 7396445 [TBL] [Abstract][Full Text] [Related]
29. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin. DuVernay VH; Pachter JA; Crooke ST Cancer Res; 1980 Feb; 40(2):387-94. PubMed ID: 7356521 [No Abstract] [Full Text] [Related]
30. [Synthesis and properties of the 14-amino derivatives of daunorubicin and carminomycin]. Povarov LS; Isaeva NN Antibiotiki; 1979 Feb; 24(2):92-6. PubMed ID: 434804 [TBL] [Abstract][Full Text] [Related]
31. [Comparison of the antitumor, immunodepressive and toxic properties of carminomycin-albumin complexes differing in carminomycin content]. Aleksander SK; Liashenko VA; Iakushkina IV Antibiotiki; 1981 Apr; 26(4):298-302. PubMed ID: 6894522 [TBL] [Abstract][Full Text] [Related]
32. [Synthesis and mass-spectrometric analysis of N-cycloalkyl derivatives of carminomycin, daunorubicin and their analogs]. Olsuf'eva EN; Rozynov BV Bioorg Khim; 1990 Jun; 16(6):847-53. PubMed ID: 2222529 [TBL] [Abstract][Full Text] [Related]
36. [Changes in the T- and B-lymphocyte ratio in bone sarcoma patients before and after carminomycin treatment]. Vatin AE; Bizer VA Antibiotiki; 1980 Nov; 25(11):864-7. PubMed ID: 6969572 [TBL] [Abstract][Full Text] [Related]
37. A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer. Fujii S; Kubo K; Johdo O; Yoshimoto A; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1986 Mar; 39(3):473-5. PubMed ID: 3700249 [No Abstract] [Full Text] [Related]
38. [Intensification of the cytostatic action of adriamycin and carminomycin by amphotericin B]. Makukho LV; Volkolupova OP; Gauze GF Antibiotiki; 1980 Apr; 25(4):294-6. PubMed ID: 7369735 [TBL] [Abstract][Full Text] [Related]
39. [Carminomycin in the therapy of leukemias]. Vygovskaia IaI; Mazurok AA; Kondrat'eva NA; Orel VG Antibiotiki; 1982 Aug; 27(8):632-5. PubMed ID: 6957161 [No Abstract] [Full Text] [Related]
40. One-electron reduction of an anthracycline antibiotic carminomycin by a human erythrocyte redox chain. Peskin AV; Bartosz G FEBS Lett; 1987 Jul; 219(1):212-4. PubMed ID: 3036597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]